Ivabradine MR CAD
Study: CL3-16257-097, a randomised, double-blind, parallel groups, multicentre trial. Safety of oral chronic administration of ivabradine MRcompared to ivabradine immediate release formulation, in patients with stable coronary artery disease.
- Stadium
- klaar
- Middel
- Ivabradine MR
- Populatie
- ASCVD
- Fase
- III
- First Patient In
- 15 november 2012
- Last Patient In
- 1 juni 2013
- Last Patient Last Visit
- -
Studiedirecteur
